Highly Effective Second-Line Anti-Helicobacter pylori Therapy in Patients with Previously Failed Metronidazole-Based Therapy

References

• Tefera S., Berstad A., Bang C. J., Nysæther G., Hatlebakk J. G., Olafsson S., et al. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain). Am J Gastroenterol 1996; 91: 935–41
   PubMed Web of Science ®Google Scholar
• Bell C. D., Bate C. M., Axon A. T R, Tildesley G., Kerr G. D., Green J. R B, et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment Pharmacol Ther 1995; 9: 513–20
   PubMed Web of Science ®Google Scholar
• de Boer W. A., Tytgat G. N J. How to treat Helicobacter pylori infection—should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint [review]. Eur J Gastoenterol Hepatol 1996; 8: 709–16
   PubMedGoogle Scholar
• Bell G. D., Powell K. U., Burridge S. M., Bowdwn A. F., Atoyebi W., Bolton G. H., et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 41–6
   PubMed Web of Science ®Google Scholar
• Peitz U., Nusch A., Tillenburg B., Stolte M., Borsch G., Labenz J. High cure rate of H. pylori infection by one-week therapy with omeprazole, metronidazole and clarithromycin despite a negative impact by metronidazole resistance. Gut 1996; 39(Suppl 2)5A
   PubMedGoogle Scholar
• Hams A. W., Pryce D. I., Gabe S. M., Karim Q. N., Walker M. M., Langworthy H., et al. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 1005–8
   PubMedGoogle Scholar
• Lerang F., Mourn B., Haug J. B., Tolas P., Breder O., Aubert E., et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?. Am J Gastroenterol 1997; 92: 248–53
   PubMedGoogle Scholar
• Borody T. J., Andrews P., Brandl S., Devine M. Relevance of in-vitro metronidazole resistance to H. pylori eradication and eradication failure. Gastroenterology 1993; 104: A44
   Google Scholar
• Borody T. J., Andrews P., Fracchia G., Brandl S., Shortis N. P., Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995; 37: 477–81
   PubMed Web of Science ®Google Scholar
• Al-Assi M. T., Ramirez P. C., Lew G. M., Genta R. M., Graham D. Y. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol 1994; 89: 1203–5
   PubMedGoogle Scholar
• Laine L., Estrada R., Trujillo M., Fukanaga K., Neil G. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996; 10: 1029–33
   PubMedGoogle Scholar
• Lerang F., Mourn B., Ragnhildstveit E., Haug J. B., Hauge T., Tolas P., et al. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection; a prospective randomized 1-yr follow-up study. Am J Gastroenterol 1997; 92: 653–8
   PubMed Web of Science ®Google Scholar
• van der Hulst R. W M, Keller J. J., Rauws E. A J, Tytgat G. N J. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996; 1: 6–19
   PubMedGoogle Scholar
• Borody T. J., Andrews P., Shortis N. P. Features of patients who fail all attempts at Helicobacter pylori (HP) eradication. Am J Gastroenterol 1994; 89: 1365
   Google Scholar
• Noach L. A., Bertola M. A., Schwarts M. P., Rauws E. A J, Tytgat G. N J. Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994; 6: 585–91
   Web of Science ®Google Scholar
• Cayla R., Zerbib F., Talbi P., Megraud F., Lamouliatte H. Pre and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995; 37(Suppl 1)55A
   Google Scholar
• Borody T. J., Shortis N. P., Chongnan J., Reyes E., O'Shea J. E. Eradication failure (EF) after H. pylori treatment—further therapies. Gastroenterology 1996; 110: A67
   Google Scholar
• Reilly T. G., Ayres R. C S, Poxon V., Walt R. P. Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer. Aliment Pharmacol Ther 1995; 9: 483–90
   PubMed Web of Science ®Google Scholar
• Seppala K., Sipponen P., Nuutinen H., Farkkila M., Anisimova S., Kosunen T. U. Intent to treat metronidazole resistant H. pylori infection to 100% of cure. Therapy with quadruple therapy and its modification. Gastroenterology 1995; 108: A216
   Google Scholar
• Moshkowitz M., Konikoff F. M., Peled Y., Brill S., Hallak A., Tiomny E., et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther 1996; 10: 1015–9
   PubMed Web of Science ®Google Scholar
• Lind T., Veldhuyzen van Zanten S., Unge P., Spiller R., Bayer-Dorffer E., O'Morain C., et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter 1996; 1: 138–44
   PubMedGoogle Scholar
• Yousfi M. M., El-Zimaity H. M T, Genta R. M., Graham D. Y. One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 617–21
   PubMedGoogle Scholar
• Labenz J., Stolte M., Peitz U., Tillenburg B., Becker T., Borsch G. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 207–10
   PubMedGoogle Scholar
• Peitz U., Tillenburg B., Becker T., Stolte M., Borsch G., Labenz J. Highly effective well tolerated one-week therapy with omeprazole, clarithromycin and amoxicillin for Helicobacter pylori (HP) infection. Gastroenterology 1996; 110: A 226
   Google Scholar
• Lamouliatte H., Cayla R., Zerbib F., Talbi P., Megraud F., de Mascarel A. Triple therapy with PPI-amoxicillin-clarithromycin for H. pylori eradication: the optimal regimen in 1996. Gastro-enterology 1996; 110: A171
   Google Scholar
• Delchier J. C., Elamine I., Goldfain D., Chaussade S., Barthelemy P., Idstrøm J. P. Omcprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996; 10: 263–8
   PubMed Web of Science ®Google Scholar
• Thijs J. C., van Zwet A. A., Moolenaar W., Ooms J. A J, de Kortes H., Runhaar E. A. Short report: clarithromycin, an alternative to metronidazole in triple therapy of Helicobacter pylori infection. Aliment Pharmacol Ther 1994; 8: 131–4
   PubMedGoogle Scholar
• Graham D. Y., de Boer W. A., Tytgat G. N J. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenlerol 1996; 91: 1072–6
   PubMed Web of Science ®Google Scholar
• Walt R. P. Metronidazole-resistant H. pylori—of questionable clinical importance. Lancet 1996; 348: 489–90
   PubMed Web of Science ®Google Scholar
• Yousfi M. M., El-Zimaity H. M T, Cole R. A., Genta R. M., Graham D. Y. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). Aliment Pharmacol Ther 1996; 10: 119–22
   PubMedGoogle Scholar
• Moayyedi P., Tompkins D. S., Mapstone N., Axon A. T R. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori. Gut 1996; 38(Suppl 1)38A
   Google Scholar
• Hulten K., Engstrand L. Acquired and persistent macrolide resistance in patients treated with clarithromycin. Gut 1996; 39(Suppl 2)8A
   Google Scholar
• Debets-Ossenkopp Y. J., Sparrius M., Kusters J. G., Kolkman C. M J. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori [abstract]. Gut 1996; 39(Suppl 2)8A
   Google Scholar